BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38567982)

  • 21. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
    Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
    Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation.
    Pasquali D; Santoro A; Bufo P; Conzo G; Deery WJ; Renzullo A; Accardo G; Sacco V; Bellastella A; Pannone G
    Thyroid; 2011 Apr; 21(4):391-9. PubMed ID: 21385081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of LC3 in Papillary Thyroid Carcinomas and Lymph Node Metastases.
    Li X; Lin X; Ma H
    Acta Chir Belg; 2015; 115(5):356-63. PubMed ID: 26560002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of SPECT/CT Lymphoscintigraphy and Radioguided Sentinel Lymph Node Biopsy in Managing Papillary Thyroid Cancer.
    Cabrera RN; Chone CT; Zantut-Wittmann DE; Matos PS; Ferreira DM; Pereira PS; Ribeiro MP; Santos AO; Ramos CD; Crespo AN; Etchebehere EC
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):834-41. PubMed ID: 27366869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Papillary thyroid carcinoma with hyperthyroidism and multiple metastases: A case report.
    Zhang LL; Liu B; Sun FF; Li HY; Li S; Zhao LR
    Medicine (Baltimore); 2020 Jul; 99(30):e21346. PubMed ID: 32791734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
    Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW
    Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
    Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
    Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
    Wen DY; Pan DH; Lin P; Mo QY; Wei YP; Luo YH; Chen G; He Y; Chen JQ; Yang H
    Mol Med Rep; 2018 Sep; 18(3):2631-2642. PubMed ID: 30015845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphovascular invasion is associated with survival for papillary thyroid cancer.
    Pontius LN; Youngwirth LM; Thomas SM; Scheri RP; Roman SA; Sosa JA
    Endocr Relat Cancer; 2016 Jul; 23(7):555-62. PubMed ID: 27317633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases.
    Le Pennec S; Konopka T; Gacquer D; Fimereli D; Tarabichi M; Tomás G; Savagner F; Decaussin-Petrucci M; Trésallet C; Andry G; Larsimont D; Detours V; Maenhaut C
    Endocr Relat Cancer; 2015 Apr; 22(2):205-16. PubMed ID: 25691441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features of incidentally detected metastatic thyroid papillary carcinoma in cervical lymph nodes of non-thyroid cancer patients: a retrospective analysis of 31cases.
    Hu C; Zhang H; Chu L; Qiu T; Lu H
    Diagn Pathol; 2023 Jul; 18(1):82. PubMed ID: 37454141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
    Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
    Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor keratin 15 expression links with less extent of invasion and better prognosis in papillary thyroid cancer patients receiving tumor resection.
    Yang X; Liu Z; Wang X; Han Z; Zhang C; Guo L
    Ir J Med Sci; 2024 Feb; 193(1):9-15. PubMed ID: 37243844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma.
    Jung TS; Kim TY; Kim KW; Oh YL; Park DJ; Cho BY; Shong YK; Kim WB; Park YJ; Jung JH; Chung JH
    Endocr J; 2007 Apr; 54(2):265-74. PubMed ID: 17379963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do black (dark) lymph-node metastases in papillary thyroid carcinoma suggest more advanced or aggressive disease?
    Crist HS; Evans JJ; Mani H; Saunders B; Fornadley J; Camacho F; Goldenberg D
    Thyroid; 2013 Aug; 23(8):977-81. PubMed ID: 23343222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the role of prophylactic bilateral central neck lymph node dissection in patients with papillary thyroid carcinoma: a case controlled study.
    Shahriarirad R; Meshkati Yazd SM; Zahedi R; Mokhtari Ardekani A; Rekabi MM; Nasiri S
    Updates Surg; 2023 Apr; 75(3):679-689. PubMed ID: 36527603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.